ATE124726T1 - Wachstumsregelfaktoren für neuriten. - Google Patents
Wachstumsregelfaktoren für neuriten.Info
- Publication number
- ATE124726T1 ATE124726T1 AT89912786T AT89912786T ATE124726T1 AT E124726 T1 ATE124726 T1 AT E124726T1 AT 89912786 T AT89912786 T AT 89912786T AT 89912786 T AT89912786 T AT 89912786T AT E124726 T1 ATE124726 T1 AT E124726T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- metalloproteases
- present
- neurites
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26794188A | 1988-11-04 | 1988-11-04 | |
US07/401,212 US5684133A (en) | 1988-11-04 | 1989-08-30 | Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE124726T1 true ATE124726T1 (de) | 1995-07-15 |
Family
ID=26952762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89912786T ATE124726T1 (de) | 1988-11-04 | 1989-11-02 | Wachstumsregelfaktoren für neuriten. |
Country Status (8)
Country | Link |
---|---|
US (2) | US6103232A (de) |
EP (1) | EP0396719B1 (de) |
KR (1) | KR100196540B1 (de) |
AT (1) | ATE124726T1 (de) |
AU (2) | AU652537B2 (de) |
DE (1) | DE68923362T2 (de) |
DK (1) | DK160190A (de) |
WO (1) | WO1990005191A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250414A (en) * | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
KR100196540B1 (ko) * | 1988-11-04 | 1999-06-15 | 마틴 이. 샤브 | 축색성장 조절인자 |
WO1993000427A2 (en) * | 1991-06-24 | 1993-01-07 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
GEP20002243B (en) * | 1991-09-20 | 2000-09-25 | Amgen Inc | Glial Derived Neurotrophic Factor |
AU5891394A (en) * | 1993-02-11 | 1994-08-29 | Erziehungsdirektion Of The Canton Zurich | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
CA2218599A1 (en) * | 1995-04-19 | 1996-10-24 | Acorda Therapeutics | Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
US6576607B1 (en) | 1995-04-19 | 2003-06-10 | Acorda Therapeutics | Methods using CNS neurite outgrowth modulators |
US6576441B1 (en) | 1995-12-06 | 2003-06-10 | Sumitomo Pharmaceuticals Company, Limited | Semaphorin Z and gene encoding the same |
WO1998011216A1 (fr) | 1996-09-11 | 1998-03-19 | Sumitomo Pharmaceuticals Company, Limited | Nouveau gene de semaphorine: semaphorine y |
US6902730B1 (en) | 1996-10-09 | 2005-06-07 | Sumitomo Pharmaceuticals Company, Limited | Semaphorin gene: Semaphorin W |
AU4964097A (en) | 1996-11-15 | 1998-06-10 | Sumitomo Pharmaceuticals Company, Limited | Novel semaphorin genes (i) |
WO1999066041A1 (en) * | 1998-06-16 | 1999-12-23 | Human Genome Sciences, Inc. | 94 human secreted proteins |
PL204293B1 (pl) | 1998-11-06 | 2009-12-31 | Univ Zuerich | Oczyszczone białko i jego zastosowanie, izolowany kwas nukleinowy, wektor do klonowania, rekombinowana komórka, sposób wytwarzania rekombinowanego białka, sposób identyfikacji rybozymu lub antysensownego kwasu nukleinowego, przeciwciało monoklonalne, zastosowanie przeciwciała, sposób wytwarzania przeciwciał poliklonalnych, izolowana próbka surowicy odpornościowej, zastosowanie surowicy odpornościowej i sposób wytwarzania przeciwciał monoklonalnych. |
AU784349C (en) | 2000-01-12 | 2006-09-28 | Yale University | Nogo receptor-mediated blockade of axonal growth |
US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
NZ525422A (en) * | 2000-10-06 | 2006-09-29 | Biogen Idec Inc | Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons |
WO2006047049A2 (en) * | 2004-10-01 | 2006-05-04 | Yale University | Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof |
EP1841464B1 (de) * | 2005-01-24 | 2012-06-27 | Alnylam Pharmaceuticals Inc. | Rnai-modulation des nogo-l oder nogo-r-gens und dessen verwendungen |
US7893032B2 (en) * | 2005-07-07 | 2011-02-22 | Yale University | NgR variants and compositions thereof for suppressing axonal growth inhibition |
CA2607668A1 (en) * | 2005-07-21 | 2007-02-01 | Alnylam Pharmaceuticals, Inc. | Rnai modulation of the rho-a gene and uses thereof |
CA2619406A1 (en) * | 2005-08-25 | 2007-03-01 | Biogen Idec Ma Inc. | Nogo receptor polypeptides and polypeptide fragments and uses thereof |
KR100756423B1 (ko) | 2005-10-27 | 2007-09-07 | 한국과학기술연구원 | 성선자극호르몬 수용체를 바이오마커로 이용한 마이엘린의탐색방법 |
EP1952147A2 (de) * | 2005-11-16 | 2008-08-06 | Novartis AG | Biomarker zur anti-nogo-a-antikörperbehandlung bei rückenmarksverletzung |
WO2007133746A2 (en) * | 2006-05-15 | 2007-11-22 | Biogen Idec Ma Inc. | Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival |
ES2609924T3 (es) * | 2006-11-21 | 2017-04-25 | Abbott Laboratories | Anticuerpos monoclonales neutralizantes contra el receptor de Nogo-66 (NGR) y usos de los mismos |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4407744A (en) * | 1977-11-23 | 1983-10-04 | Young David M | Process for obtaining nerve growth factor |
US4287184A (en) * | 1977-11-23 | 1981-09-01 | The Massachusetts General Hospital | Process for healing wounds |
US4230691A (en) * | 1978-05-23 | 1980-10-28 | The Massachusetts General Hospital | Nerve growth factor antibody and process |
CA1173823A (en) * | 1980-08-26 | 1984-09-04 | Leonard M. Hjelmeland | Nondenaturing zwitterionic detergent for membrane biochemistry |
US4444760A (en) * | 1983-06-17 | 1984-04-24 | Merck & Co., Inc. | Purification and characterization of a protein fibroblast growth factor |
CA1341401C (en) * | 1984-03-23 | 2002-11-26 | Adriano Fontana | Immunosuppressant factor derived from human glioblastoma cells |
EP0155433A1 (de) * | 1984-03-23 | 1985-09-25 | Adriano Fontana | Immunsuppressionsfaktor |
US4803163A (en) * | 1984-06-04 | 1989-02-07 | E. I. Du Pont De Nemours And Company | Preparation of a protein fraction exhibiting cell growth-inhibiting activity |
EP0233838A3 (de) * | 1986-02-04 | 1990-01-31 | Incyte Pharmaceuticals, Inc. | Neuriten stimulierender Faktor und Prozess für seine Herstellung |
US4923696A (en) * | 1987-05-04 | 1990-05-08 | Baylor College Of Medicine | Method to prepare a neurotrophic composition |
KR100196540B1 (ko) * | 1988-11-04 | 1999-06-15 | 마틴 이. 샤브 | 축색성장 조절인자 |
US5250414A (en) * | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
-
1989
- 1989-11-02 KR KR1019900701436A patent/KR100196540B1/ko not_active IP Right Cessation
- 1989-11-02 WO PCT/EP1989/001321 patent/WO1990005191A1/en active IP Right Grant
- 1989-11-02 AT AT89912786T patent/ATE124726T1/de not_active IP Right Cessation
- 1989-11-02 AU AU45280/89A patent/AU652537B2/en not_active Expired
- 1989-11-02 EP EP89912786A patent/EP0396719B1/de not_active Expired - Lifetime
- 1989-11-02 DE DE68923362T patent/DE68923362T2/de not_active Expired - Lifetime
-
1990
- 1990-07-03 DK DK160190A patent/DK160190A/da not_active IP Right Cessation
-
1994
- 1994-09-30 AU AU74354/94A patent/AU680932B2/en not_active Ceased
-
1995
- 1995-06-05 US US08/464,509 patent/US6103232A/en not_active Expired - Lifetime
- 1995-06-05 US US08/462,312 patent/US6025333A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR900702050A (ko) | 1990-12-05 |
AU4528089A (en) | 1990-05-28 |
DE68923362D1 (de) | 1995-08-10 |
WO1990005191A1 (en) | 1990-05-17 |
EP0396719A1 (de) | 1990-11-14 |
AU680932B2 (en) | 1997-08-14 |
EP0396719B1 (de) | 1995-07-05 |
US6025333A (en) | 2000-02-15 |
DK160190D0 (da) | 1990-07-03 |
DK160190A (da) | 1990-09-03 |
AU652537B2 (en) | 1994-09-01 |
DE68923362T2 (de) | 1996-03-28 |
US6103232A (en) | 2000-08-15 |
AU7435494A (en) | 1994-12-15 |
KR100196540B1 (ko) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE124726T1 (de) | Wachstumsregelfaktoren für neuriten. | |
GR3033103T3 (en) | Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases | |
ES2149888T3 (es) | 3-(3,4-dioxifenil)-pirrolidinas como inhibidores de la fosfodiesterasa de tipo iv para el tratamiento de enfermedades inflamatorias. | |
ATE323482T1 (de) | Verwendung von p38 mapk inhibitoren in der behandlung von augenkrankheiten | |
MX9604985A (es) | Cardiotropina y usos de la misma. | |
ATE154758T1 (de) | Levobupivacain nützlich zur behandlung von chronischen schmerzen | |
DE69233478T8 (de) | Neue menschliche cdc25 gene, kodierte produkte und ihre verwendung | |
DE69633336D1 (de) | Zusamenzetzung enthaltend einen inhibitor des myelin assoziierten glycoproteins (mag), welcher einer veränderten oder mutierten form von mag enthält | |
MX2022011518A (es) | Metodos para tratar deambulacion asociada a proteinopatia. | |
WO1993000427A3 (en) | Neurite growth regulatory factors | |
DE69636934D1 (de) | Verwendung von aromatischen oder verzweigten aminosäuren zur behandlung von bewegungsstörungen | |
WO2003103573A3 (en) | METHODS OF TREATING A NEUROLOGICAL DISORDER BY PERIPHERAL DELIVERY OF A TROPHIC FACTOR | |
DE60137414D1 (de) | Zusammensetzungen zur stimulierung der regeneration und der wiederherstellung des nervensystems durch regulierung der arginase 1- und polyamin-synthese | |
ATE369143T1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
DE59609977D1 (de) | Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern | |
ATE80998T1 (de) | Verwendung von nalmefen zur herstellung eines arzneimittels zur behandlung der schaedigung des zentralnervensystems. | |
ES8105392A1 (es) | Procedimiento de obtencion de una solucion de aminoacidos y peptidos de origen animal por proceso enzimatico | |
ATE391915T1 (de) | Verwendung des proteins grf-1 zur auswahl von molekülen | |
ES8702910A1 (es) | Procedimiento para la obtencion de benzodiazepinas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |